Amyotrophic lateral sclerosis (ALS), also known as “Lou Gehrig’s Disease,” is a devastating fatal disease of the nervous system that kills two to five Canadians every day. On September 19th and 20th, the Montreal Neurological Institute and Hospital (The Neuro), at McGill University and the McGill University Health Centre will host the 10th Annual ALS Symposium of the Fondation André-Delambre. Nearly one hundred researchers and clinicians from several countries will come together to discuss recent progress in ALS research.
Dr. Peter McPherson, James McGill Professor of Neurology and Neurosurgery, and Anatomy and Cell Biology at the Montreal Neurological Institute, McGill University has been named a Fellow of the Royal Society of Canada (RSC).
Canadians have a duty to increase access to dental care
September 1st, 2014
Dr. Alan Evans, a pioneering scientist who has helped map the human brain, has been awarded the Margolese National Brain Disorders Prize by the University of British Columbia. Dr. Evans is a researcher at the Montreal Neurological Institute and the James McGill Professor of Neurology and Neurosurgery, Psychiatry and Biomedical Engineering at McGill University.
McGill University is mourning the passing of Rosalind Goodman, a devoted alumna, generous philanthropist, and tireless volunteer, who committed herself to energizing cancer research activities at McGill and to educating others about the disease. It is an illness she fought and survived in 2007, but one that ultimately took her life on Monday, Aug. 11.
With this issue of the spotlight, we would like to congratulate Dr. Brett Thombs who is the recipient of the 2014 Principal’s Prize for Outstanding Emergent Researchers. This award was created in 2013 to encourage and celebrate McGill’s most outstanding earl-career researchers, as well as to provide them with an advantage as they apply for external awards by adding a prestigious internal distinction to their list of accomplishments.
Click to view: Department of Psychiatry Newsletter - Summer 2014
Please join us in congratulating the recipients of the CIHR operating grants competition.
Scientists at the Montreal Neurological Institute and Hospital, McGill University and McGill University Health Centre have shown that a member of the protein family known as SUMO (small ubiquitin-like modifier) is a key to why tumour cells multiply uncontrollably, especially in the case of glioblastoma. The SUMO family proteins modify other proteins and the SUMOylation of proteins are critical for many cellular processes.
The Quartier de l’innovation de Montréal (QI) is proud to announce the appointment of Damien Silès as Executive Director. Mr. Silès, who is currently serving as General Manager of the Société de développement social de Ville-Marie, will take up his duties with the QI on July 16, 2014.